Brief: Brain Biotech 9-Month Adjusted Group EBITDA Loss Widens To EUR 2.2 Mln

BRAIN Biotech AG

30/08/2021 06:39

Aug 30 (Reuters) - BRAIN BIOTECH AG  BNNn.DE :
    * RELEASES 9M '20/'21 RESULTS
    * FULL YEAR GUIDANCE CONFIRMED
    * IN FIRST NINE MONTHS OF 2020/2021 FINANCIAL YEAR, BRAIN
GROUP
GENERATED A REVENUE OF EUR 27.8 MILLION COMPARED TO EUR 29.6
MILLION IN SAME PERIOD OF PREVIOUS YEAR, WHICH REPRESENTS A
DECLINE OF 5.8%.
    * ADJUSTED GROUP EBITDA DECREASED BY EUR 1.6 MILLION FROM
EUR -0.6
MILLION IN PREVIOUS YEAR TO EUR -2.2 MILLION IN FIRST NINE
MONTHS OF 2020/21 FINANCIAL YEAR.

Source text for Eikon:  ID:nEQ3ph6Fva 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))